scientific publications
and communications

PATAS, a First-in-Class Therapeutic Peptide Biologic, Improves Whole-Body Insulin Resistance and Associated Comorbidities In Vivo

Edwige Schreyer; Cathy Obringer; Nadia Messaddeq; Bruno Kieffer; Paul Zimmet; Alexander Fleming; Tarekegn Geberhiwot; Vincent Marion

Diabetes

13/07/2022

71(9)

2034–2047

AdipoPharma SAS – Headquarters
Nextmed, Bâtiment eXplora (Bureau A203)1907
2 rue Marie Hamm
67000 Strasbourg
France

AdipoPharma SRL
Biopark Gosselies
Belgique

AdipoPharma LLC
US Office Pittsburgh
Pennsylvania, USA

© 2025 AdipoPharma - Privacy Policy | Legal Notice | Management Of The Information Collected